Concepedia

Ben Lane

BL

Statistics

Publications

9

Citations

529

H-Index

9

Active since

1984

Affiliations

Abbott Fund(Current)

Ligand Pharmaceuticals (United States)

Abbott (United Kingdom)

Abbott (United States)

Ben Lane is an author at Abbott Fund specializing in pharmacology, life sciences, and steroid hormone signaling.

Publications per year

1984–2004

9

Publications

9

A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects

Michael J. Coghlan, Peer B. Jacobson, Ben Lane et al. · Molecular Endocrinology · 2003 · 221 citations

, , +17

Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators

Steven W. Elmore, John K. Pratt, Michael J. Coghlan et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 57 citations · Full text

, , +16

A Nonsteroidal Glucocorticoid Receptor Antagonist

Jeffrey N. Miner, Curtis M. Tyree, Junlian Hu et al. · Molecular Endocrinology · 2003 · 55 citations · Full text

, , +17

trans-Activation and Repression Properties of the Novel Nonsteroid Glucocorticoid Receptor Ligand 2,5-Dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and Its Four Stereoisomers

Chun Wel Lin, Masaki Nakane, Mike Stashko et al. · Molecular Pharmacology · 2002 · 50 citations

, , +17

FKBP12-FK506 Complex Inhibits Phosphatase Activity of Two Mammalian Isoforms of Calcineurin Irrespective of Their Substrates or Activation Mechanisms11

Hideyuki Mukai, T Kuno, Chang‐Duk Chang et al. · The Journal of Biochemistry · 1993 · 43 citations

, , +13

1–5 of 9